[Arguments in favor of the early treatment of Parkinson's disease with L-Dopa].
Broussolle
E
E
Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Lyon.
D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D007980:Levodopa / Q000494:pharmacology / Q000627:therapeutic use*; D008017:Life Expectancy; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D000978:Antiparkinson Agents; D005609:Free Radicals; D007980:Levodopa